CVS Health (CVS) Tops Q3 EPS by 20c, Lifts FY EPS Guidance
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $88.84 -1.58%
EPS Growth %: +2.5%
Financial Fact:
Cost of revenues: 37.12B
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: +2.5%
Financial Fact:
Cost of revenues: 37.12B
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q3 EPS of $1.97, $0.20 better than the analyst estimate of $1.77. Revenue for the quarter came in at $73.79 billion versus the consensus estimate of $70.4 billion.
GUIDANCE:
CVS Health sees FY2021 EPS of $7.90-$8.00, versus the consensus of $7.79.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Barclays says AI trade is maturing, favors greater diversification
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
